Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$6.6M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 11 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 28 most recent Form 4 transactions.
| $1.1M |
| -53.5% |
| Open the original filing on SEC.gov |
| Jun 23 | PTGX | Protagonist Therapeutics,… | MEXER◷ | 9,000 | $16.54 | $148.9K | +115.0% | Open the original filing on SEC.gov |
| Jun 11 | ANNX | Annexon, Inc. | AGRANT◆ | 65,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 10 | PTGX | Protagonist Therapeutics,… | MEXER◷◆ | 6,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 10 | PTGX | Protagonist Therapeutics,… | MEXER◷◆ | 3,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 10 | PTGX | Protagonist Therapeutics,… | SSELL◷ | 9,000 | $107.68 | $969.1K | -53.5% | Open the original filing on SEC.gov |
| Jun 10 | PTGX | Protagonist Therapeutics,… | MEXER◷ | 6,000 | $16.54 | $99.2K | +55.4% | Open the original filing on SEC.gov |
| Jun 10 | PTGX | Protagonist Therapeutics,… | MEXER◷ | 3,000 | $11.80 | $35.4K | +38.3% | Open the original filing on SEC.gov |
| May 29 | PTGX | Protagonist Therapeutics,… | MEXER◷◆ | 9,000 | — | — | — | Open the original filing on SEC.gov |
| May 29 | PTGX | Protagonist Therapeutics,… | SSELL◷ | 9,000 | $99.64 | $896.8K | -53.5% | Open the original filing on SEC.gov |
| May 29 | PTGX | Protagonist Therapeutics,… | MEXER◷ | 9,000 | $11.80 | $106.2K | +115.0% | Open the original filing on SEC.gov |
| Feb 6 | PTGX | Protagonist Therapeutics,… | MEXER◆ | 20,000 | — | — | — | Open the original filing on SEC.gov |
| Feb 6 | PTGX | Protagonist Therapeutics,… | SSELL | 20,000 | $83.68 | $1.7M | -71.9% | Open the original filing on SEC.gov |
| Feb 6 | PTGX | Protagonist Therapeutics,… | MEXER | 20,000 | $8.31 | $166.2K | +255.6% | Open the original filing on SEC.gov |
| Jan 2 | PTGX | Protagonist Therapeutics,… | AGRANT◆ | 3,762 | — | — | — | Open the original filing on SEC.gov |
| Jan 2 | PTGX | Protagonist Therapeutics,… | AGRANT | 2,695 | — | — | +52.5% | Open the original filing on SEC.gov |
| Dec 19, 2025 | ARWR | Arrowhead Pharmaceuticals,… | SSELL◷ | 500 | $68.53 | $34.3K | -0.9% | Open the original filing on SEC.gov |
| Dec 19, 2025 | ARWR | Arrowhead Pharmaceuticals,… | SSELL◷ | 5,451 | $68.01 | $370.7K | -8.7% | Open the original filing on SEC.gov |
| Dec 19, 2025 | ARWR | Arrowhead Pharmaceuticals,… | SSELL◷ | 2,416 | $66.66 | $161.1K | -3.7% | Open the original filing on SEC.gov |
| Dec 16, 2025 | ARWR | Arrowhead Pharmaceuticals,… | AGRANT | 7,819 | — | — | +13.7% | Open the original filing on SEC.gov |
| Oct 10, 2025 | PTGX | Protagonist Therapeutics,… | MEXER◷◆ | 12,000 | — | — | — | Open the original filing on SEC.gov |
| Oct 10, 2025 | PTGX | Protagonist Therapeutics,… | SSELL◷ | 8,000 | $87.81 | $702.5K | -60.9% | Open the original filing on SEC.gov |
| Oct 10, 2025 | PTGX | Protagonist Therapeutics,… | SSELL◷ | 4,000 | $69.25 | $277K | -23.4% | Open the original filing on SEC.gov |
| Oct 10, 2025 | PTGX | Protagonist Therapeutics,… | MEXER◷ | 12,000 | $6.98 | $83.8K | +233.9% | Open the original filing on SEC.gov |
| Sep 22, 2025 | PTGX | Protagonist Therapeutics,… | SSELL◷ | 4,000 | $64.25 | $257K | -43.8% | Open the original filing on SEC.gov |
| Aug 27, 2025 | PTGX | Protagonist Therapeutics,… | SSELL◷ | 4,000 | $59.25 | $237K | -30.5% | Open the original filing on SEC.gov |
| Jun 5, 2025 | ANNX | Annexon, Inc. | AGRANT◆ | 55,000 | — | — | — | Open the original filing on SEC.gov |